Hasil Pencarian - Chao‐Hua Chiu
- Menampilkan 1 - 20 hasil dari 20
-
1
-
2
-
3
Impending myxedema coma as the initial presentation of lung cancer oleh Chia-I Shen, Hsu-Ching Huang, Yi-Chen Yeh, Chao-Hua Chiu
Diterbitkan 2017-06-01
Artikel -
4
-
5
Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report oleh Chia-I Shen, MD, Yi-Chen Yeh, MD, Chao-Hua Chiu, MD
Diterbitkan 2021-05-01
Artikel -
6
Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy? oleh Hsuan-Hsuan Yu, Yi-Wei Chen, Yi-Chen Yeh, Chien-Sheng Huang, Chao-Hua Chiu
Diterbitkan 2021-06-01
Artikel -
7
Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer oleh Chi-Lu Chiang, Chi-Lu Chiang, Chi-Lu Chiang, Chia-I Shen, Chia-I Shen, Chia-I Shen, Hsu-Ching Huang, Hsu-Ching Huang, Han-Jhih Chang, Yu-Ting Huang, Chao-Hua Chiu, Chao-Hua Chiu
Diterbitkan 2022-01-01
Artikel -
8
Dynamic Assessment of Tissue and Plasma <i>EGFR</i>-Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Can... oleh Hsiang-Ling Ho, Fang-Yu Wang, Chi-Lu Chiang, Chun-Ming Tsai, Chao-Hua Chiu, Teh-Ying Chou
Diterbitkan 2022-09-01
Artikel -
9
-
10
-
11
Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer oleh Chia-I Shen, Heng-Sheng Chao, Tsu-Hui Shiao, Chi-Lu Chiang, Hsu-Ching Huang, Yung-Hung Luo, Chao-Hua Chiu, Yuh-Min Chen
Diterbitkan 2021-08-01
Artikel -
12
Reduced FEV1 as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors oleh Yi-Luen Shen, Yi-Luen Shen, Chia-I Shen, Chia-I Shen, Chia-I Shen, Chi-Lu Chiang, Chi-Lu Chiang, Chi-Lu Chiang, Hsu-Ching Huang, Hsu-Ching Huang, Kun-Ta Chou, Kun-Ta Chou, Kun-Ta Chou, Chao-Hua Chiu, Chao-Hua Chiu, Yuh-Min Chen, Yuh-Min Chen, Yung-Hung Luo, Yung-Hung Luo
Diterbitkan 2022-03-01
Artikel -
13
Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell‐free DNA from non‐small‐cell lung cancer patients with leptomeningeal metastases oleh Chi‐Lu Chiang, Hsiang‐Ling Ho, Yi‐Chen Yeh, Cheng‐Chia Lee, Hsu‐Ching Huang, Chia‐I Shen, Yung‐Hung Luo, Yuh‐Min Chen, Chao‐Hua Chiu, Teh‐Ying Chou
Diterbitkan 2023-05-01
Artikel -
14
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer. oleh Hsiang-Ling Ho, Yuqiu Jiang, Chi-Lu Chiang, Sylwia Karwowska, Ranga Yerram, Keerti Sharma, Sidney Scudder, Chao-Hua Chiu, Chun-Ming Tsai, John F Palma, Abha Sharma, Teh-Ying Chou
Diterbitkan 2022-01-01
Artikel -
15
Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer. oleh Hsiu-Ying Hung, Yen-Han Tseng, Heng-Sheng Chao, Chao-Hua Chiu, Wen-Hu Hsu, Han-Shui Hsu, Yu-Chung Wu, Teh-Ying Chou, Chun-Ku Chen, Keng-Li Lan, Yi-Wei Chen, Yuan-Hung Wu, Yuh-Min Chen
Diterbitkan 2020-01-01
Artikel -
16
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids oleh Yuan‐Hung Wu, Heng‐sheng Chao, Chi‐Lu Chiang, Yung‐Hung Luo, Chao‐Hua Chiu, Sang‐Hue Yen, Chun‐Yu Liu, Jeng‐Fong Chiou, Thierry Burnouf, Yin‐Ju Chen, Peng‐Yuan Wang, Tsu‐Yi Chao, Shih‐Ming Hsu, Long‐Sheng Lu
Diterbitkan 2023-09-01
Artikel -
17
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan oleh Yuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, Inn-Wen Chong, Te-Chun Hsia, Meng-Chih Lin, Gee-Chen Chang, Chao-Hua Chiu, Chao-Chi Ho, Shang-Yin Wu, Jen-Yu Hung, Chin-Chou Wang, Tsung-Ying Yang, Chong-Jen Yu
Diterbitkan 2020-12-01
Artikel -
18
Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 pat... oleh Yuan‐Hung Wu, Yu‐Mei Kang, Yu‐Wen Hu, Keng‐Li Lan, Sang‐Hue Yen, Tzu‐Yu Lai, Tien‐Li Lan, Yuh‐Min Chen, Chao‐Hua Chiu, Yung‐Hung Luo, Heng‐sheng Chao, Chi‐Lu Chiang, Tsu‐Hui Shiao, Chao‐Neng Yang, Wen‐Hu Hsu, Yu‐Chung Wu, Han‐Shui Hsu, Jung‐Jyh Hung, Chien‐Sheng Huang, Po‐Kuei Hsu, Yi‐Wei Chen
Diterbitkan 2023-03-01
Artikel -
19
Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC oleh Alexander Drilon, MD, Chao-Hua Chiu, MD, Yun Fan, MD, Byoung Chul Cho, MD, PhD, Shun Lu, MD, PhD, Myung-Ju Ahn, MD, PhD, Matthew G. Krebs, MD, PhD, Stephen V. Liu, MD, Thomas John, MD, Gregory A. Otterson, MD, Daniel S.W. Tan, MD, Tejas Patil, MD, Rafal Dziadziuszko, MD, PhD, Erminia Massarelli, MD, PhD, Takashi Seto, MD, Robert C. Doebele, MD, PhD, Bethany Pitcher, MSc, Nino Kurtsikidze, MD, Sebastian Heinzmann, PhD, Salvatore Siena, MD
Diterbitkan 2022-06-01
Artikel -
20
Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC oleh Qing Zhou, MD, PhD, Ross A. Soo, MBBS, PhD, Gee-Chen Chang, MD, PhD, Chao-Hua Chiu, MD, Hidetoshi Hayashi, MD, PhD, Sang-We Kim, MD, PhD, Shunsuke Teraoka, MD, Yasushi Goto, MD, PhD, Jianying Zhou, MD, Victor Ho-Fun Lee, MD, Dong-Wan Kim, MD, PhD, Baohui Han, MD, PhD, James Chung Man Ho, MD, FRCP, Chia-Chi Lin, MD, PhD, Shun Lu, MD, Anna Polli, BS, Anna Maria Calella, PhD, Jean-François Martini, PhD, Chew Hooi Wong, PhD, Tony Mok, MD, Hye Ryun Kim, MD, PhD, Yi-Long Wu, MD
Diterbitkan 2023-05-01
Artikel